Medical Device User Fee and Modernization Act of 2002

Pub. L. 107–250

US Codex doesn’t hold the enacted text of this law — the public-law corpus runs from the 113th Congress (2013) onward. What it changed in the U.S. Code, reconstructed from the credit notes, is listed below.

15 sections of the Code credited to this law, found between Public Law 107-136 and Public Law 107-377.

• 21 U.S.C. § 321 — Definitions; generally
• 21 U.S.C. § 331 — Prohibited acts
• 21 U.S.C. § 333 — Penalties
• 21 U.S.C. § 335a — Debarment, temporary denial of approval, and suspension
• 21 U.S.C. § 352 — Misbranded drugs and devices
• 21 U.S.C. § 353 — Exemptions and consideration for certain drugs, devices, and biological products
• 21 U.S.C. § 360 — Registration of producers of drugs or devices
• 21 U.S.C. § 360c — Classification of devices intended for human use
• 21 U.S.C. § 360e — Premarket approval
• 21 U.S.C. § 360m — Accredited persons
• 21 U.S.C. § 374 — Inspection
• 21 U.S.C. § 379i — Definitions
• 21 U.S.C. § 379j — Authority to assess and use device fees
• 42 U.S.C. § 289g-3 — 289g–3. Breast implant research
• 42 U.S.C. § 289g–3 — Breast implant research